TEAS Response to Suspension Inquiry

ABECMA

Celgene Corporation

Response to Suspension Inquiry or Letter of Suspension

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1822 (Rev 10/2011)
OMB No. 0651-0050 (Exp 09/20/2020)

Response to Suspension Inquiry or Letter of Suspension


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88202247
LAW OFFICE ASSIGNED LAW OFFICE 124
MARK SECTION
MARK http://uspto.report/TM/88202247/mark.png
LITERAL ELEMENT ABECMA
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size or color.
FOREIGN REGISTRATION
The applicant herein submits a digitized image of a copy, a certification, or a certified copy of a registration in the applicant's country of origin showing that the mark has been registered in that country, and that the registration is in full force and effect. If the foreign registration is not in English, an English translation thereof is being submitted. The applicant hereby requests removal of this application from suspension for further action by the examining attorney.
       FOREIGN REGISTRATION
       COUNTRY
United Kingdom
       FOREIGN REGISTRATION NUMBER 00003355015
       FOREIGN REGISTRATION
       DATE
11/20/2018
       FOREIGN EXPIRATION DATE 11/20/2028
       DATE FOREIGN REGISTRATION
       RENEWED
        (if applicable)
11/20/2028
       FOREIGN REGISTRATION FILE NAME(S)
       ORIGINAL PDF FILE FR_3898229178-155131368_._ABECMA.pdf
       CONVERTED PDF FILE(S)
       (1 page)
\\TICRS\EXPORT17\IMAGEOUT17\882\022\88202247\xml5\RSI0002.JPG
GOODS AND/OR SERVICES SECTION (current)
INTERNATIONAL CLASS 005
DESCRIPTION
Pharmaceutical preparations for use in the treatment of multiple myeloma, blood disease, cancer, diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
FILING BASIS Section 1(b)
FILING BASIS Section 44(d)
        FOREIGN APPLICATION NUMBER UK0000335501
       FOREIGN APPLICATION COUNTRY United Kingdom
        FOREIGN FILING DATE 11/21/2018
GOODS AND/OR SERVICES SECTION (proposed)
INTERNATIONAL CLASS 005
DESCRIPTION
Pharmaceutical preparations for use in the treatment of multiple myeloma, blood disease, cancer, diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
FILING BASIS Section 44(d)
       FOREIGN APPLICATION NUMBER UK0000335501
       FOREIGN APPLICATION COUNTRY United Kingdom
       FOREIGN FILING DATE 11/21/2018
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
DELETED FILING BASIS 1(b)
FILING BASIS Section 44(e)
       FOREIGN REGISTRATION NUMBER 00003355015
       FOREIGN REGISTRATION
       COUNTRY
United Kingdom
       FOREIGN REGISTRATION
       DATE
11/21/2018
       FOREIGN EXPIRATION DATE 11/21/2028
       DATE FOREIGN REGISTRATION
       RENEWED
        (if applicable)
11/21/2028
       STANDARD CHARACTERS
       OR EQUIVALENT
NO
ADDITIONAL STATEMENTS SECTION
MISCELLANEOUS STATEMENT Applicant has had a bona fide and effective industrial or commercial establishment in the United Kingdom as of the date of the foreign registration. Applicant wishes to delete the 1(b) basis and proceed soley on 44(d) and 44(e).
ATTORNEY SECTION (current)
NAME Camille M. Miller
ATTORNEY BAR MEMBERSHIP NUMBER NOT SPECIFIED
YEAR OF ADMISSION NOT SPECIFIED
U.S. STATE/ COMMONWEALTH/ TERRITORY NOT SPECIFIED
FIRM NAME COZEN O'CONNOR
INTERNAL ADDRESS SUITE 2800
STREET 1650 MARKET STREET
CITY PHILADELPHIA
STATE Pennsylvania
COUNTRY US
PHONE 215-665-7273
FAX 2157012273
EMAIL cmiller@cozen.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
DOCKET/REFERENCE NUMBER CELG-1846US/
OTHER APPOINTED ATTORNEY Camille M. Miller
ATTORNEY SECTION (proposed)
NAME Camille M. Miller
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Cozen O'Connor
INTERNAL ADDRESS Suite 2800
STREET 1650 Market Street
CITY Philadelphia
STATE Pennsylvania
POSTAL CODE 19103
COUNTRY United States
PHONE 215-665-7273
FAX 2157012273
EMAIL cmiller@cozen.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
DOCKET/REFERENCE NUMBER CELG-1846US/
OTHER APPOINTED ATTORNEY Melanie A. Miller, J. Trevor Cloak, Chanel L. Lattimer, Brianne L. Polito, Ashley Kessler, Mayura Noordyke, Kevin Gibbs
CORRESPONDENCE SECTION (current)
NAME CAMILLE M. MILLER
FIRM NAME COZEN O'CONNOR
INTERNAL ADDRESS SUITE 2800
STREET 1650 MARKET STREET
CITY PHILADELPHIA
STATE Pennsylvania
COUNTRY US
PHONE 215-665-7273
FAX 2157012273
EMAIL cmiller@cozen.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
DOCKET/REFERENCE NUMBER CELG-1846US/
OTHER APPOINTED ATTORNEY Camille M. Miller
CORRESPONDENCE SECTION (proposed)
NAME Camille M. Miller
FIRM NAME Cozen O'Connor
INTERNAL ADDRESS Suite 2800
STREET 1650 Market Street
CITY Philadelphia
STATE Pennsylvania
POSTAL CODE 19103
COUNTRY United States
PHONE 215-665-7273
FAX 2157012273
EMAIL cmiller@cozen.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
DOCKET/REFERENCE NUMBER CELG-1846US/
SIGNATURE SECTION
DECLARATION SIGNATURE /Camille M. Miller/
SIGNATORY'S NAME Camille M. Miller
SIGNATORY'S POSITION attorney
SIGNATORY'S PHONE NUMBER 2156657273
DATE SIGNED 08/14/2019
RESPONSE SIGNATURE /Camille M. Miller/
SIGNATORY'S NAME Camille M. Miller
SIGNATORY'S POSITION attorney
SIGNATORY'S PHONE NUMBER 2156657273
DATE SIGNED 08/14/2019
AUTHORIZED SIGNATORY YES
FILING INFORMATION SECTION
SUBMIT DATE Wed Aug 14 16:03:45 EDT 2019
TEAS STAMP USPTO/RSI-XX.XX.XXX.XXX-2
0190814160345636460-88202
247-610b6517fca77c36c8bd5
77b6d43a487b13f9bf447b304
a744dc8db32a14abf9081-N/A
-N/A-20190814155131368277



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1822 (Rev 10/2011)
OMB No. 0651-0050 (Exp 09/20/2020)

Response to Suspension Inquiry or Letter of Suspension


To the Commissioner for Trademarks:

Application serial no. 88202247 ABECMA(Standard Characters, see http://uspto.report/TM/88202247/mark.png) has been amended as follows:
FOREIGN REGISTRATION
The applicant herein submits a digitized image of a copy, a certification, or a certified copy of a registration in the applicant's country of origin showing that the mark has been registered in that country, and that the registration is in full force and effect. If the foreign registration is not in English, an English translation thereof is being submitted. The applicant hereby requests removal of this application from suspension for further action by the examining attorney.

Filing Basis: Section 44(e), Based on Foreign Registration: A copy of United Kingdom registration number 00003355015 registered 11/20/2018, with a renewal date of 11/20/2028 and an expiration date of 11/20/2028, and translation thereof (if appropriate), is attached in accordance with 15 U.S.C. Section 1126(e), as amended.
Original PDF file:
FR_3898229178-155131368_._ABECMA.pdf
Converted PDF file(s) (1 page)
Foreign Registration-1
CLASSIFICATION AND LISTING OF GOODS/SERVICES
Applicant proposes to amend the following class of goods/services in the application:
Current: Class 005 for Pharmaceutical preparations for use in the treatment of multiple myeloma, blood disease, cancer, diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Original Filing Basis:
Filing Basis: Section 1(b), Intent to Use: The applicant has had a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or services as of the filing date of the application. (15 U.S.C. Section 1051(b)).

Filing Basis: Section 44(d), Priority based on foreign filing: Applicant has had a bona fide intention to use the mark in commerce on or in connection with the identified goods and/or services, and asserts a claim of priority based on [United Kingdom application number UK0000335501 filed 11/21/2018]. 15 U.S.C.Section 1126(d), as amended.

Proposed: Class 005 for Pharmaceutical preparations for use in the treatment of multiple myeloma, blood disease, cancer, diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Deleted Filing Basis: 1(b)
Filing Basis: Section 44(d), Priority based on foreign filing: Applicant has a bona fide intention to use the mark in commerce on or in connection with the identified goods and/or services, and asserts a claim of priority based on [United Kingdom application number UK0000335501 filed 11/21/2018]. 15 U.S.C.Section 1126(d), as amended.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.

Filing Basis: Section 44(e), Based on Foreign Registration: Applicant has a bona fide intention to use the mark in commerce on or in connection with the identified goods and /or services, and will submit a copy of [ United Kingdom registration number 00003355015 registered 11/21/2018 with a renewal date of 11/21/2028 and an expiration date of 11/21/2028 ], and translation thereof, if appropriate, before the application may proceed to registration. 15 U.S.C. Section 1126(e), as amended.


ADDITIONAL STATEMENTS
Miscellaneous Statement
Applicant has had a bona fide and effective industrial or commercial establishment in the United Kingdom as of the date of the foreign registration. Applicant wishes to delete the 1(b) basis and proceed soley on 44(d) and 44(e).

The applicant's current attorney information: Camille M. Miller. Other appointed attorneys are Camille M. Miller. Camille M. Miller of COZEN O'CONNOR, and the attorney(s) is located at

      SUITE 2800
      1650 MARKET STREET
      PHILADELPHIA, Pennsylvania
      US
The docket/reference number is CELG-1846US/.

The phone number is 215-665-7273.

The fax number is 2157012273.

The email address is cmiller@cozen.com

The applicants proposed attorney information: Camille M. Miller. Other appointed attorneys are Melanie A. Miller, J. Trevor Cloak, Chanel L. Lattimer, Brianne L. Polito, Ashley Kessler, Mayura Noordyke, Kevin Gibbs. Camille M. Miller of Cozen O'Connor, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at

      Suite 2800
      1650 Market Street
      Philadelphia, Pennsylvania 19103
      United States
The docket/reference number is CELG-1846US/.

The phone number is 215-665-7273.

The fax number is 2157012273.

The email address is cmiller@cozen.com

Camille M. Miller submitted the following statement: I attest that I am an attorney who is an active member in good standing of the bar of the highest court of a U.S. state (including the District of Columbia and any U.S. Commonwealth or territory).
The applicant's current correspondence information: CAMILLE M. MILLER. Other appointed attorneys are Camille M. Miller. CAMILLE M. MILLER of COZEN O'CONNOR, and the attorney(s) is located at

      SUITE 2800
      1650 MARKET STREET
      PHILADELPHIA, Pennsylvania
      US
The docket/reference number is CELG-1846US/.

The phone number is 215-665-7273.

The fax number is 2157012273.

The email address is cmiller@cozen.com

The applicants proposed correspondence information: Camille M. Miller. Camille M. Miller of Cozen O'Connor, is located at

      Suite 2800
      1650 Market Street
      Philadelphia, Pennsylvania 19103
      United States
The docket/reference number is CELG-1846US/.

The phone number is 215-665-7273.

The fax number is 2157012273.

The email address is cmiller@cozen.com

Declaration Signature

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that, if the applicant submitted the application or amendment to allege use (AAU) unsigned, all statements in the application or AAU and this submission based on the signatory's own knowledge are true, and all statements in the application or AAU and this submission made on information and belief are believed to be true.

STATEMENTS FOR UNSIGNED SECTION 1(a) APPLICATION/AAU: If the applicant filed an unsigned application under 15 U.S.C. §1051(a) or AAU under 15 U.S.C. §1051(c), the signatory additionally believes that: the applicant is the owner of the mark sought to be registered; the mark is in use in commerce and was in use in commerce as of the application or AAU filing date; the original specimen(s), if applicable, shows the mark in use in commerce as of the filing date of the application or AAU on or in connection with the goods/services/collective membership organization in the application or AAU; for a collective trademark, collective service mark, collective membership mark, or certification mark application, the applicant is exercising legitimate control over the use of the mark in commerce and was exercising legitimate control over use of the mark in commerce as of the application or AAU filing date; for a certification mark application, the applicant is not engaged in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant. To the best of the signatory's knowledge and belief, no other persons, except, if applicable, authorized users, members, and/or concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

STATEMENTS FOR UNSIGNED SECTION 1(b)/SECTION 44 APPLICATION AND FOR SECTION 66(a) COLLECTIVE/CERTIFICATION MARK APPLICATION: for a trademark or service mark application, the applicant believes the applicant is entitled to use the mark in commerce on or in connection with the goods/services specified in the application; the applicant has a bona fide intention to use the mark in commerce and had a bona fide intention to use the mark in commerce as of the application filing date; the signatory is properly authorized to execute the declaration on behalf of the applicant; for a collective trademark, collective service mark, collective membership mark, or certification mark application, the applicant has a bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce and had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce as of the application filing date; the signatory is properly authorized to execute the declaration on behalf of the applicant; for a certification mark application, the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program of the goods/services that meet the certification standards of the applicant. To the best of the signatory's knowledge and belief, no other persons, except, if applicable, authorized users, members, and/or concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

Signature: /Camille M. Miller/    Date: 08/14/2019
Signatory's Name: Camille M. Miller
Signatory's Position: attorney
Signatory's Phone Number: 2156657273

Response Suspension Inquiry Signature
Signature: /Camille M. Miller/     Date: 08/14/2019
Signatory's Name: Camille M. Miller
Signatory's Position: attorney
Signatory's Phone Number: 2156657273

The signatory has confirmed that he/she is a U.S.-licensed attorney who is an active member in good standing of the bar of the highest court of a U.S. state (including the District of Columbia and any U.S. Commonwealth or territory); and he/she is currently the owner's/holder's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another U.S.-licensed attorney not currently associated with his/her company/firm previously represented the owner/holder in this matter: the owner/holder has revoked their power of attorney by a signed revocation or substitute power of attorney with the USPTO; the USPTO has granted that attorney's withdrawal request; the owner/holder has filed a power of attorney appointing him/her in this matter; or the owner's/holder's appointed U.S.-licensed attorney has filed a power of attorney appointing him/her as an associate attorney in this matter.

Mailing Address:    CAMILLE M. MILLER
   COZEN O'CONNOR
   SUITE 2800
   1650 MARKET STREET
   PHILADELPHIA, Pennsylvania
Mailing Address:    Camille M. Miller
   Cozen O'Connor
   Suite 2800
   1650 Market Street
   Philadelphia, Pennsylvania 19103
        
Serial Number: 88202247
Internet Transmission Date: Wed Aug 14 16:03:45 EDT 2019
TEAS Stamp: USPTO/RSI-XX.XX.XXX.XXX-2019081416034563
6460-88202247-610b6517fca77c36c8bd577b6d
43a487b13f9bf447b304a744dc8db32a14abf908
1-N/A-N/A-20190814155131368277


TEAS Response to Suspension Inquiry [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed